Tivozanib + Enzalutamide in Adv Prostate Cancer
Clinical trial NCT01885949 · TERMINATED
Trial details
- NCT number
- NCT01885949
- Sponsor
- Massachusetts General Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-03
- Primary completion
- 2024-05-23
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.